SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Care-plan review) — Marie Curie — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMarie Curie
Date of birth1867-11-07
IdentifiersMRN HR-ET013-SYN-TD; SSN (made up) 000-13-2758
Document date1934-06-29
AuthorAdaeze Nwosu, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week review on immunosuppressive therapy, one week after laser capsulotomy. [S]

History of Present Illness

Madame Curie returns six weeks after starting immunosuppressive therapy. She has had no fever, infection, or bleeding, and the bruising has lessened. She has a little more energy in the afternoons. She takes cyclosporine, eltrombopag, and acyclovir as prescribed. Ophthalmology confirmed posterior capsule opacification in the right eye two weeks ago and performed a YAG laser capsulotomy one week ago. She now reads standard print without glare, with no eye pain, redness, new floaters, flashes, or shadow in her vision. She is frustrated at being away from her laboratory. [S]

ElementDetail
Infection and bleedingNone; fewer bruises
EnergyA little better in the afternoons
AdherenceCyclosporine, eltrombopag, and acyclovir as prescribed
EyeLaser capsulotomy one week ago; reading standard print without glare
After laserNo pain, redness, new floaters, flashes, or shadow
MoodFrustrated at time away from the laboratory

Review of Systems

SystemResultFinding
ConstitutionalPositiveFatigue improving; no fever
HematologicNegativeNo new bruising or bleeding
EyesNegativeClear reading vision on the right; no pain, floaters, flashes, or shadow
SkinNegativeNo rash
PsychiatricPositiveFrustrated at time away from work; sleeping and eating well; PHQ-2 score 2

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Cyclosporine (modified) 100 mg oral capsule, one capsule twice daily, dose adjusted to trough levels by hematologyOne capsule by mouth twice daily; hematology adjusts the dose to trough levelsOral route1934-05-18activeS
Eltrombopag 75 mg oral tablet, two tablets (150 mg) once daily on an empty stomachTwo tablets by mouth once daily, two hours before or four hours after food, dairy, or antacidsOral route1934-05-18activeS
Acyclovir 400 mg oral tablet, one tablet twice daily during immunosuppressionOne tablet by mouth twice dailyOral route1934-05-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1934-06-29Body height157cmS
1934-06-29Body weight52kgS
1934-06-29Body mass index (BMI) [Ratio]21.1kg/m2S
1934-06-29Systolic blood pressure128mm[Hg]S
1934-06-29Diastolic blood pressure78mm[Hg]S
1934-06-29Heart rate86/minS
1934-06-29Respiratory rate16/minS
1934-06-29Body temperature36.7CelS
1934-06-29Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1934-06-29Hemoglobin [Mass/volume] in Blood8.9g/dL11.6-15 g/dLLowS
1934-06-29Leukocytes [#/volume] in Blood by Automated count2.410*3/uL4-11 10*3/uLLowS
1934-06-29Neutrophils [#/volume] in Blood by Automated count0.810*3/uL1.5-7.5 10*3/uLLowS
1934-06-29Platelets [#/volume] in Blood by Automated count3410*3/uL150-400 10*3/uLLowS
1934-06-29MCV [Entitic mean volume] in Red Blood Cells by Automated count101fL80-100 fLHighS
1934-06-29Reticulocytes [#/volume] in Blood by Automated count3110*3/uL25-100 10*3/uLNormalS
1934-06-29Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L7-35 U/LNormalS
1934-06-29Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
1934-06-29Potassium [Moles/volume] in Serum or Plasma4.9mmol/L3.5-5.1 mmol/LNormalS
1934-06-29Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.59-1.04 mg/dLNormalS
1934-06-29Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1929)/1.73 sq M61mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1934-06-29Glucose [Mass/volume] in Serum or Plasma98mg/dL70-99 mg/dLNormalS
1934-06-29Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]2{score}S

Physical Exam

Vital signs recorded on 1934-06-29; see the Vital Signs section. [S]

SystemFinding
GeneralLess pale; alert and engaged
MouthNo ulcers, thrush, or gum swelling
SkinFading bruises on the shins; no petechiae
HeartRegular rhythm, pulse 86
EyesRight red reflex now clear; both eyes white and quiet

Problems

ProblemClinical statusVerificationCodeProvenance
Severe aplastic anemia: pancytopenia with a low reticulocyte count, confirmed by a hypocellular bone marrow; attributed to cumulative occupational ionizing radiation; linked to the documented 1842 diagnosisactiveconfirmed D61.2S — Synthetic modern diagnosis; the 1934 report remains D and the radiation cause is R.
Occupational exposure to ionizing radiation over decades of radium research and X-ray workactiveconfirmed Z57.1S — Synthetic modern coding of the documented exposure history.
Posterior capsule opacification, right eye, after earlier bilateral cataract surgery; glare and blurred reading visionactiveconfirmed H26.491S — Synthetic eye finding linked to the documented cataracts and operations.
Chronic radiodermatitis of the fingertips, with thin, scarred skinactiveconfirmed L58.1S — Synthetic skin finding linked to the documented finger burns.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryCBC with differential and reticulocyte countWeekly during the first months of treatmentCompleted todayHemoglobin 8.9 g/dL, white cells 2.4, neutrophils 0.8, platelets 34, reticulocytes 31 thousand per microliter
LaboratoryWeekly blood counts between visitsWeekly during the first months of treatmentDeferredAgain no counts are in this record between visits, a second deviation from the protocol. Counts are rising with no bleeding or infection, so no harm resulted. Corrective action: weekly counts confirmed with the hematology day unit
LaboratoryCreatinine, eGFR, potassium, and ALT on cyclosporine and eltrombopagEvery two weeks during the first months of treatmentCompleted todayThree weeks after the last check, a week late. Creatinine 1.02 mg/dL (about 30 percent above baseline), eGFR 61, potassium 4.9, ALT 31
LaboratoryCyclosporine trough levelRegularly from the first weeks of treatment, to guide the doseDeferredStill no trough level in this record, a second deviation from the protocol. The creatinine rise now warrants a dose review. Corrective action: hematology contacted today for a trough and dose review
LaboratoryViral serology before immunosuppression (hepatitis B, hepatitis C, HIV, CMV, EBV)At diagnosis, before immunosuppressionDeferredStill not in this record. ALT remains normal. Corrective action: hematology asked again today
ExaminationBlood pressure and weight on cyclosporineEvery visitCompleted today128/78 mmHg; weight 52 kg
Medication safetyAntiviral prophylaxis during immunosuppressionThroughout immunosuppressionCompleted todayTaking acyclovir twice daily
Medication safetyAntibacterial and antifungal prophylaxis while severely neutropenicWhile neutrophils are below 0.5 thousand per microliter, by local policyNot indicatedNeutrophils 0.8, above the severe-neutropenia range
Self-managementSame-day assessment for a temperature of 38 °C or higher; bleeding precautions; no aspirin or NSAIDsEvery visitCompleted todayNo fever; plan reviewed
SurveySymptom assessment (fatigue, breathlessness, exercise tolerance)Every visit during active treatmentCompleted todayEnergy a little better in the afternoons
ExaminationComprehensive dilated eye examinationEvery 1 to 2 years at 65 or olderUp to dateDone by ophthalmology two weeks ago: 20/60 right and 20/30 left before laser, normal pressure, no retinal hemorrhages
ExaminationPressure check after laser capsulotomyAfter the laserDeferredNo post-laser pressure reading is in this record. No pain, halos, or loss of vision, and reading has improved, so no harm is apparent. Corrective action: request the laser-day note from ophthalmology
Self-managementWarning signs of retinal detachment after capsulotomyAfter the laserCompleted todayReviewed: new floaters, flashes, or a shadow need a same-day call
SurveyFunctional vision assessment (reading, driving, work)After treatmentCompleted todayReading standard print without glare
SurveyDepression screen (PHQ-2)Periodically during serious illnessCompleted todayScore 2, negative; frustration at time away from work
SurveyResponse assessment (blood counts off transfusion)At three and six monthsDueAt three months

Goal progress:

Guideline basis: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024); Cataract in the Adult Eye Preferred Practice Pattern (2021); CMID: Clinical Monitoring Intelligence Database, anemia and cataract monographs (2026)

Follow-up: Weekly blood counts with creatinine and potassium this week. Primary care review in three weeks. Formal response assessment at three months. [S]